William O. Sandals

Array ( [id] => 7640426 [patent_doc_number] => 06395487 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Method chromosomal rearrangement by consecutive gene targeting of two recombination substrates to the deletion endpoints' [patent_app_type] => B1 [patent_app_number] => 09/552219 [patent_app_country] => US [patent_app_date] => 2000-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 32 [patent_no_of_words] => 10443 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395487.pdf [firstpage_image] =>[orig_patent_app_number] => 09552219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1426508 [patent_doc_number] => 06504020 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-07 [patent_title] => 'Isolated nucleic acids comprising Listeria dal and dat genes' [patent_app_type] => B1 [patent_app_number] => 09/520207 [patent_app_country] => US [patent_app_date] => 2000-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 31 [patent_no_of_words] => 14365 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/504/06504020.pdf [firstpage_image] =>[orig_patent_app_number] => 09520207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1600057 [patent_doc_number] => 06475794 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Converting diploidy to haploidy for genetic diagnosis' [patent_app_type] => B1 [patent_app_number] => 09/504860 [patent_app_country] => US [patent_app_date] => 2000-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 6394 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/475/06475794.pdf [firstpage_image] =>[orig_patent_app_number] => 09504860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1377864 [patent_doc_number] => 06555366 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-29 [patent_title] => 'Nucleotide sequences for the control of the expression of DNA sequences in a cell host' [patent_app_type] => B1 [patent_app_number] => 09/503252 [patent_app_country] => US [patent_app_date] => 2000-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 14429 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/555/06555366.pdf [firstpage_image] =>[orig_patent_app_number] => 09503252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1524401 [patent_doc_number] => 06353092 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => 'Patched-2 polypeptide' [patent_app_type] => B1 [patent_app_number] => 09/500063 [patent_app_country] => US [patent_app_date] => 2000-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10671 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/353/06353092.pdf [firstpage_image] =>[orig_patent_app_number] => 09500063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1534251 [patent_doc_number] => 06489104 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Human p27Kip1 gene promoter' [patent_app_type] => B1 [patent_app_number] => 09/492639 [patent_app_country] => US [patent_app_date] => 2000-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 8086 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 240 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489104.pdf [firstpage_image] =>[orig_patent_app_number] => 09492639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1410060 [patent_doc_number] => 06524796 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Human P27KIP1 gene promoter' [patent_app_type] => B1 [patent_app_number] => 09/491971 [patent_app_country] => US [patent_app_date] => 2000-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 8091 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/524/06524796.pdf [firstpage_image] =>[orig_patent_app_number] => 09491971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1298995 [patent_doc_number] => 06623925 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-23 [patent_title] => 'Human p27Kip1 gene promoter' [patent_app_type] => B1 [patent_app_number] => 09/491970 [patent_app_country] => US [patent_app_date] => 2000-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 8084 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/623/06623925.pdf [firstpage_image] =>[orig_patent_app_number] => 09491970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416351 [patent_doc_number] => 06514695 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Compositions and methods for intraductal gene therapy' [patent_app_type] => B1 [patent_app_number] => 09/488464 [patent_app_country] => US [patent_app_date] => 2000-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 12428 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514695.pdf [firstpage_image] =>[orig_patent_app_number] => 09488464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1474071 [patent_doc_number] => 06387659 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Process for producing S-hydroxynitrile lyase' [patent_app_type] => B1 [patent_app_number] => 09/472146 [patent_app_country] => US [patent_app_date] => 1999-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4480 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387659.pdf [firstpage_image] =>[orig_patent_app_number] => 09472146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404440 [patent_doc_number] => 06232105 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Conditional replication and expression system' [patent_app_type] => 1 [patent_app_number] => 9/355434 [patent_app_country] => US [patent_app_date] => 1999-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 18758 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/232/06232105.pdf [firstpage_image] =>[orig_patent_app_number] => 355434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550056 [patent_doc_number] => 06399374 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Converting diploidy to haploidy for genetic diagnosis' [patent_app_type] => B1 [patent_app_number] => 09/461047 [patent_app_country] => US [patent_app_date] => 1999-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 6305 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399374.pdf [firstpage_image] =>[orig_patent_app_number] => 09461047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1577908 [patent_doc_number] => 06448093 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Hydrophobe biomolecular structure' [patent_app_type] => B1 [patent_app_number] => 09/455472 [patent_app_country] => US [patent_app_date] => 1999-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10422 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/448/06448093.pdf [firstpage_image] =>[orig_patent_app_number] => 09455472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1410395 [patent_doc_number] => 06524816 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Expression element' [patent_app_type] => B1 [patent_app_number] => 09/367891 [patent_app_country] => US [patent_app_date] => 1999-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14216 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/524/06524816.pdf [firstpage_image] =>[orig_patent_app_number] => 09367891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1507099 [patent_doc_number] => 06440728 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus' [patent_app_type] => B1 [patent_app_number] => 09/450972 [patent_app_country] => US [patent_app_date] => 1999-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 16 [patent_no_of_words] => 19504 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440728.pdf [firstpage_image] =>[orig_patent_app_number] => 09450972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636689 [patent_doc_number] => 06379966 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-04-30 [patent_title] => 'Intravascular delivery of non-viral nucleic acid' [patent_app_type] => B2 [patent_app_number] => 09/450315 [patent_app_country] => US [patent_app_date] => 1999-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15063 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/379/06379966.pdf [firstpage_image] =>[orig_patent_app_number] => 09450315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4415957 [patent_doc_number] => 06194159 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Facile method for identifying regulated promoters' [patent_app_type] => 1 [patent_app_number] => 9/449083 [patent_app_country] => US [patent_app_date] => 1999-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12142 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194159.pdf [firstpage_image] =>[orig_patent_app_number] => 449083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1436132 [patent_doc_number] => 06355776 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Peptides comprising repetitive units of amino acids and DNA sequences encoding the same' [patent_app_type] => B1 [patent_app_number] => 09/444791 [patent_app_country] => US [patent_app_date] => 1999-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 47987 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355776.pdf [firstpage_image] =>[orig_patent_app_number] => 09444791 [rel_patent_id] =>[rel_patent_doc_number] =>)